Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

NCT03343197 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

DRUG: AG-120
DRUG: AG881

Sponsor

Institut de Recherches Internationales Servier